Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments

Exclusion Criteria

• •Men and women aged \> 70 years.
• •Diagnosis of cancer, stage IV or other types of cancer.
• •Last chemotherapy session \< 6 months or \> 6 years.
• •No cognitive impairment (MMSE score between 30 and 27 points).
• •Diagnosis of mental disorder (including substance abuse) prior to cancer diagnosis.
• •Relapse in disease after chemotherapy treatment is completed.
• •Neurodevelopmental Disorder Diagnosis.
• •Diagnosis of diseases that affect cognitive performance such as: hypertension, cardiac diseases, epilepsy, dementias, multiple sclerosis, functional disorders (fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, post-concussion syndrome, whiplash syndrome), CNS infections (HIV, encephalitis), metabolic disorders (diabetes, B12 deficiency), obstructive sleep apnea, brain damage (stroke, TBI, CNS cancer) and use of medications / substances that interfere with cognitive function such as pregabalin, gabapentin, topiramate, antidepressants tricyclics, sodium valproate, anticholinergics, methylphenidate, typical antipsychotics.